![]()
|
|
||||||||
From the
1 From the Laboratory of Clinical Biochemistry and Experimental Therapeutics Branch, National Heart Institute, and Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Reduced ferredoxin is capable of reducing nonenzymatically cyano-B12. Spectral studies have shown that B12r (a 1-electron reduced derivative of the vitamin) accumulates in the reaction although the formation of methyl-B12 was observed upon the addition of methyl iodide to the incubation. The data indicate that reduction of cyano-B12 by reduced ferredoxin results in the transient formation of B12s (a 2-electron reduced derivative), which is not stable under the conditions used, and oxidizes to the more stable B12r.
Reduced ferredoxin is able to supply the reducing-capability necessary for the enzymatic conversion of cyano-B12 to deoxyadenosyl-B12.
Submitted on July 19, 1965
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |